Skip to content
Matrix Global Advisors
Matrix Global Advisors
  • Home
  • About
  • News
  • Our Work
  • Contact
  • Home
  • About
  • News
  • Our Work
  • Contact
Aug112017
News

Experts Say Proposal for Value-Based Pricing of Antimicrobials “Has Potential”

Alex Brill was recently interviewed by FDAnews about the effectiveness of incentives for drug manufacturers to develop antimicrobials:

“Former FDA commissioner Mark McClellan has put forward a proposal for value-based pricing of antimicrobials, and pricing experts tell FDAnews it has potential. McClellan, now director of the Duke-Margolis Center for Health Policy at Duke University, proposes a publicly funded market entry reward independent of sales volume once the product is approved. The reward would pay out over a five- to six-year period. The Priority Antimicrobial Value and Entry (PAVE) Award would incentivize drugmakers to develop high-priority antimicrobials. McClellan said the current fee-for-service model fails to account for features specific to the antimicrobial industry, because the primary driver of return on investment is sales volume, which can lead to overuse and antimicrobial resistance. ‘The PAVE award is an interesting and encouraging proposal geared toward shifting reimbursement towards value-based metrics,’ said Matrix Global Advisors founder and CEO Alex Brill. ‘This proposal might be further strengthened if in addition to the ‘carrot’ for improved reimbursement models for new products, a ‘stick’ to discourage inappropriate over-utilization of existing products was also included.'”

Read Here (Subscription Required)

August 11, 2017Category: News

Post navigation

PreviousPrevious post:We’re Paying the Bill for Opioid CrisisNextNext post:Shop Online? Internet Retailers Have a Tax Advantage Congress Must End
  • Analysis(29)
  • Books(2)
  • Events(13)
  • Interviews(37)
  • News(46)
  • Op-Eds(63)
  • Press Releases(2)
  • Testimony(19)
  • Alex Brill Talks Trade Disruption Due to Suez Canal Blockage on i24 News
    March 31, 2021
  • Alex Brill Featured in Foundation for Economic Education Article
    March 26, 2021
  • U.S. Spending and Tax Policy After the COVID Recessions: Political Economy Podcast
    March 24, 2021
  • Alex Brill Testifies Before U.S. Senate on Lowering Prescription Drug Prices
    March 23, 2021

Website Design and Developed by DreamBig Creative